Recombinant Mouse Diacylglycerol O-acyltransferase 2 (Dgat2)

What is the molecular structure of mouse Dgat2?

Mouse Dgat2 is a 38.6 kDa multipass membrane protein consisting of 334 amino acids . The protein contains two transmembrane domains with both the N-terminal and C-terminal regions facing the cytosol . The first transmembrane domain (TMD1) is critical for endoplasmic reticulum (ER) targeting, while the second transmembrane domain (TMD2) appears to have distinct functions . The protein's full-length sequence includes regions that are highly conserved across species, with human DGAT2 sharing 95% amino acid sequence identity with mouse DGAT2 over amino acids 268-377 .

What are the primary catalytic functions of Dgat2?

Dgat2 catalyzes the final step in triglyceride biosynthesis by transferring an acyl group from acyl-CoA to diacylglycerol (DG) . This enzymatic reaction is critical for:

• Formation of triglycerides for energy storage

• Assembly of very low-density lipoprotein (VLDL) particles in hepatocytes

• Resynthesis of triglycerides in enterocytes during dietary fat absorption

Unlike its homolog MOGAT2 (also known as DGAT2L5), which preferentially catalyzes the formation of diacylglycerol from 2-monoacylglycerol and fatty acyl-CoA, Dgat2's primary function is the final acylation step in the triglyceride synthesis pathway .

What expression systems yield functional recombinant mouse Dgat2?

Based on available research data, several expression systems have been successfully employed to produce recombinant mouse Dgat2:

• Cell-free expression systems: These have been used to produce recombinant mouse Dgat2 with ≥85% purity as determined by SDS-PAGE . This approach may help overcome challenges associated with membrane protein expression.

• E. coli-based systems: For human DGAT2, E. coli-derived recombinant forms (amino acids 268-377) have been successfully produced . Similar approaches can be adapted for mouse Dgat2.

• Mammalian expression systems: HEK293T and COS-7 cells have been utilized for expression of Dgat2 in functional studies, particularly when investigating subcellular localization and protein-protein interactions .

What are the optimal storage conditions for maintaining Dgat2 stability?

For extended storage of recombinant mouse Dgat2, the following conditions are recommended:

• Store at -20°C or preferably -80°C for long-term storage

• Avoid repeated freeze-thaw cycles, as these can decrease enzymatic activity

• For working solutions, store aliquots at 4°C for up to one week

• Inclusion of glycerol (typically 10-20%) in storage buffers helps maintain protein stability during freeze-thaw cycles

How does the subcellular localization of Dgat2 impact its function?

Dgat2 demonstrates a complex pattern of subcellular localization that directly influences its biological functions:

• Endoplasmic Reticulum (ER): The primary site of Dgat2 localization, where it participates in triglyceride synthesis within the ER membrane .

• Mitochondria: Dgat2 co-localizes with mitochondria, suggesting a potential role in coupling lipid synthesis with energy metabolism .

• Lipid Droplets: Upon oleate loading or increased triglyceride synthesis, Dgat2 translocates to the surface of lipid droplets, where it may facilitate their expansion .

Research has demonstrated that the dual localization of Dgat2 allows for compartmentalized triglyceride synthesis, which may be particularly important during metabolic adaptations such as fasting or high-fat feeding .

What molecular determinants control Dgat2 trafficking between subcellular compartments?

The trafficking of Dgat2 between different subcellular compartments is governed by specific structural elements:

• ER targeting: The first transmembrane domain (TMD1) contains the ER targeting signal. Studies have shown that when fused to a fluorescent reporter, TMD1 alone is sufficient to target the fusion protein to the ER .

• Mitochondrial association: A Dgat2 mutant lacking both transmembrane domains localizes primarily to mitochondria, suggesting that these domains normally prevent mitochondrial targeting .

• Lipid droplet association: The C-terminus of Dgat2 is essential for interaction with lipid droplets. Truncation or deletion of regions within the C-terminus prevents Dgat2 from co-localizing with lipid droplets even when cells are stimulated with oleate .

Does Dgat2 function as a monomer or within a complex?

Dgat2 functions as part of a multimeric complex consisting of several Dgat2 subunits . This oligomerization appears to be functionally significant for the following reasons:

• Native Dgat2 forms approximately 680 kDa complexes, suggesting homo-multimerization of the 38.6 kDa protein .

• The multimeric structure may facilitate efficient channeling of lipid intermediates during triglyceride synthesis.

• Complex formation may also play a role in regulating the subcellular distribution of Dgat2 between the ER, mitochondria, and lipid droplets .

Research techniques such as co-immunoprecipitation and chemical crosslinking have been instrumental in demonstrating the multimeric nature of Dgat2 .

How can researchers investigate Dgat2 protein-protein interactions?

To investigate Dgat2 protein-protein interactions, several approaches can be employed:

• Co-immunoprecipitation: Using antibodies against Dgat2 or potential interaction partners to pull down protein complexes from cell lysates.

• Fluorescence microscopy with tagged constructs: Employing fluorescently tagged Dgat2 variants to visualize co-localization with other proteins or cellular structures .

• Proximity ligation assays: These can detect interactions between Dgat2 and other proteins when they are within 40 nm of each other.

• FRET/BRET analysis: These techniques can detect direct interactions between appropriately tagged Dgat2 and other proteins in live cells.

When designing such experiments, it's important to consider that the transmembrane domains and C-terminus of Dgat2 may be involved in protein-protein interactions, so tagging strategies should be carefully selected to avoid disrupting these regions .

What are the optimal conditions for assaying recombinant mouse Dgat2 activity in vitro?

For optimal enzymatic activity assays of recombinant mouse Dgat2:

• pH and buffer conditions: Dgat2 typically shows optimal activity at pH 7.0-7.5 in HEPES or Tris-based buffers.

• Substrate preparation: Diacylglycerol substrates often require preparation with phospholipids to form mixed micelles or liposomes for accessibility to the enzyme.

• Acyl-CoA selection: Dgat2 can utilize various acyl-CoA species, with a preference for unsaturated fatty acyl-CoAs (e.g., oleoyl-CoA) .

• Detergent considerations: Low concentrations of non-ionic detergents (e.g., 0.1% Triton X-100) may be necessary to maintain enzyme solubility while preserving activity.

• Detection methods: Activity can be measured by quantifying radioactive triglyceride formation using [14C]-labeled acyl-CoA, or through non-radioactive methods such as LC-MS/MS quantification of triglyceride products.

How can substrate specificity of Dgat2 be accurately determined?

To accurately assess Dgat2 substrate specificity:

• Acyl-CoA preference: Test a range of acyl-CoA species varying in chain length and saturation level under identical reaction conditions.

• Diacylglycerol preference: Compare activity with diacylglycerols containing different fatty acid compositions at the sn-1 and sn-2 positions.

• Competitive assays: Perform assays with mixtures of different substrates to determine relative preferences when multiple substrates are available simultaneously.

• Kinetic analysis: Determine Km and Vmax values for different substrates to quantitatively assess substrate preferences.

Mouse Dgat2, like its human homolog, may show preferences for specific acyl-CoA species, with research on related enzymes suggesting preferences for unsaturated fatty acids in the order of C18:3 > C18:2 > C18:1 > C18:0 .

How can recombinant Dgat2 mutants help elucidate structure-function relationships?

Structure-function studies using Dgat2 mutants have provided valuable insights:

• Transmembrane domain mutants: A Dgat2 mutant lacking both transmembrane domains still maintains enzymatic activity but localizes to mitochondria rather than the ER, demonstrating that ER localization is not absolutely required for catalytic function .

• C-terminal mutants: Truncation or deletion of C-terminal regions prevents lipid droplet association while potentially maintaining catalytic activity, indicating distinct domains for enzymatic function versus subcellular targeting .

• Catalytic domain mutations: Targeted mutations in the acyltransferase domain can help identify specific residues involved in substrate binding and catalysis.

These approaches can be particularly valuable when designing experiments to:

• Separate the effects of protein localization from enzymatic activity

• Understand the contribution of different domains to substrate specificity

• Identify potential regions for therapeutic targeting

What methods are most effective for studying Dgat2's role in lipid droplet formation?

To investigate Dgat2's role in lipid droplet formation and expansion:

• Live cell imaging: Using fluorescently tagged Dgat2 constructs (ensuring tags don't disrupt localization signals) combined with lipid droplet stains like BODIPY or Nile Red to visualize real-time association during lipid loading .

• Pulse-chase experiments: Employing labeled fatty acids to trace their incorporation into triglycerides and subsequent lipid droplet formation in the presence of wild-type versus mutant Dgat2.

• Proximity labeling techniques: BioID or APEX2 fused to Dgat2 can identify proteins in close proximity at lipid droplet surfaces.

• Correlative light and electron microscopy: This can provide ultrastructural details of Dgat2 localization during different stages of lipid droplet formation.

Research has shown that the C-terminus of Dgat2 is particularly important for lipid droplet association, as mutants with truncations or deletions in this region fail to co-localize with lipid droplets even when cells are oleate-loaded to stimulate triglyceride synthesis .

How can researchers overcome issues with recombinant Dgat2 protein aggregation?

Dgat2 aggregation can be mitigated through several approaches:

• Optimized detergent selection: Screen multiple detergents (CHAPS, DDM, Triton X-100) at varying concentrations to find optimal solubilization conditions.

• Expression temperature reduction: Lower expression temperatures (16-20°C) can reduce inclusion body formation in bacterial systems.

• Fusion partners: Addition of solubility-enhancing tags such as MBP (maltose-binding protein) or SUMO can reduce aggregation.

• Co-expression with chaperones: Co-expressing molecular chaperones like GroEL/ES or DnaK/J can improve folding.

• Lipid supplementation: Including phospholipids in purification buffers may help stabilize the membrane protein structure.

When aggregation cannot be completely eliminated, size exclusion chromatography should be used as a final purification step to isolate properly folded, non-aggregated protein fractions.

What are common pitfalls in interpreting Dgat2 localization studies?

When conducting and interpreting Dgat2 localization studies, researchers should be aware of several potential pitfalls:

• Overexpression artifacts: Excessive expression can lead to mislocalization or aggregation that doesn't reflect physiological distribution. Use inducible expression systems with titrated expression levels.

• Tagging interference: Fluorescent or epitope tags may disrupt localization signals, particularly if placed near the transmembrane domains or C-terminus. Compare N- and C-terminally tagged versions and validate with untagged protein detection .

• Cell type variations: Dgat2 localization patterns may vary between cell types due to differences in lipid metabolism. Always relate findings to the physiological context of the cell type used.

• Dynamic trafficking: Dgat2 localization is highly responsive to metabolic conditions, so standardizing conditions for feeding state, lipid availability, and energy status is crucial for reproducible results .

• Fixation artifacts: Some fixation methods can disrupt membrane structures or lipid droplets. Comparing multiple fixation techniques or using live cell imaging can help validate observations.